Originally published by our sister publication Infectious Disease Special Edition
By Meaghan Lee Callaghan
Although specific products have been shown to be effective for recurrent Clostridioides difficile infections (CDIs), issues with cost and access have prevented some hospitals from using them, according to a presentation at MAD-ID 2025, in Orlando, Fla.
Rachel Kenney, PharmD, BCIDP, a pharmacy specialist in antimicrobial stewardship at Henry Ford Hospital, in Detroit, discussed